NCT02288520View on ClinicalTrials.gov

Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis

CompletedOBSERVATIONAL

Enrollment

854

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Rheumatoid Arthritis

Trial Locations (1)

75007

Nordic Pharma, Paris

Sponsors

Lead Sponsor

Nordic Pharma SAS

All Listed Sponsors

lead

Nordic Pharma SAS

INDUSTRY

NCT02288520 - Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter